Pin5 - 10 Years of Human Papillomavirus Systematic Vaccination in Spain: Forecasting Health Outcomes Considering As04-Hpv16/18 Vaccine Effectiveness Data

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1325
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of 2-Dose AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Efficacy, Effectiveness and Safety of Vaccination Against Human Papillomavirus in Males: A Systematic Review

BMC Medicine
Medicine
2018English

Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica

Cancer Discovery
Oncology
2011English

Cost-Effectiveness of Two-Dose Human Papillomavirus Vaccination in Singapore

Singapore Medical Journal
Medicine
2018English

Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination in Mainland China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine

Drugs
Pharmacology
2011English

Total Vaccine Cold Chain Volume Needed for Human Papillomavirus Vaccination in Bangladesh

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness Calculations of Human Papillomavirus Vaccination in Punjab May Be Flawed

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy